Clinical Trials · NCT02198209
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- Cedars-Sinai Medical Center
- Enrollment
- 0
- Start date
- Dec 2019
- Locations
- 1 site, United States
- Primary endpoint
- Liver glucokinase activity (acute effect)